HIE, Hypoxic ischemic encephalopathy is a severe kind of disease that happens because of a lack of oxygen and blood flow to the brain. It often occurs during birth timing. This can lead to significant brain damage, neurological deficits, and even death. Traditional treatments for HIE are primarily supportive and aimed at minimizing further brain injury, such as therapeutic hypothermia. It helps in lowering the body temperature to reduce metabolic demand and subsequent neuronal damage. However, these treatments do not repair the damage already done, highlighting the need for innovative therapies to improve outcomes for affected infants.
Stem cell therapy has emerged as a promising approach to treating HIE due to its potential to repair and regenerate damaged brain tissue. Mesenchymal stem cells (MSCs) and neural stem cells (NSCs) are the most commonly studied types for this purpose. These stem cells can differentiate into many brain cells. It releases neurotrophic factors that promote neurogenesis, reduce inflammation, and protect existing neurons. Experimental studies in animal models have shown that stem cell treatment can improve cognitive and motor functions, reduce brain lesion size, and enhance overall neurological outcomes. These promising preclinical results have led to early-phase clinical trials to assess safety and efficacy in human infants with HIE.
The clinical application of stem cell therapy for HIE includes harvesting stem cells from sources like umbilical cord blood, bone marrow, or even autologous sources from the patient. These cells are then processed and administered to the patient intravenously or directly into the brain. Early clinical trials have reported encouraging results, with improved motor function and reduced neurological deficits in treated infants. However, further research is needed to optimize treatment protocols, determine long-term outcomes, and ensure the safety and efficacy of this innovative therapy. If successful, stem cell treatment could revolutionize the management of HIE. It offers hope for improved neurodevelopmental outcomes in affected children.
Hypoxic-ischemic encephalopathy (HIE) is a serious condition resulting from a lack of oxygen and blood flow to the brain, typically occurring around the time of birth. The symptoms of HIE can vary depending on the severity and duration of the oxygen deprivation. They are generally categorized based on the clinical severity into mild, moderate, and severe HIE. Given below are some key symptoms associated with each severity level:
Neonatal Symptoms:
In newborns, symptoms of HIE can be immediate and severe. They may include:
– Low Apgar Scores: Newborns with HIE often have low Apgar scores, which measure a baby’s color, heart rate, reflexes, muscle tone, and respiration at one and five minutes after birth.
– Difficulty Breathing: Infants may require resuscitation or mechanical ventilation.
– Seizures: Seizures are a common early sign of HIE and can occur within 24 to 48 hours after birth.
– Abnormal Muscle Tone: Infants may exhibit either hypotonia (low muscle tone) or hypertonia (high muscle tone), affecting their movements and posture.
– Feeding Difficulties: Difficulty with sucking and swallowing can occur.
– Altered Consciousness: Newborns with HIE may be sluggish, unresponsive, or have a reduced level of consciousness.
Long-Term Symptoms:
As the child grows, the long-term effects of HIE may become apparent, including:
– Developmental Delays: Children may experience delays in reaching milestones such as crawling, walking, and speaking.
– Cognitive Impairments: Learning disabilities, intellectual disabilities, and memory issues can arise.
– Motor Impairments: Cerebral palsy, characterized by impaired movement and coordination, is a common outcome of HIE.
– Seizure Disorders: Epilepsy can develop as a long-term complication.
– Behavioral and Emotional Issues: Attention deficits, hyperactivity, and behavioral problems may be present.
Other Possible Symptoms:
– Vision and Hearing Problems: Impairments in vision and hearing can occur due to damage to specific brain areas.
– Feeding and Growth Issues: Ongoing difficulty with feeding and growth may persist.
The severity and combination of these symptoms depend on the extent and location of the brain damage. Early diagnosis and intervention are crucial for improving outcomes and providing supportive therapies to manage symptoms and enhance quality of life.
Hypoxic Ischemic Encephalopathy (HIE) is categorized based on the severity of the brain injury and its clinical manifestation. This category helps guide treatment decisions and predict the outcomes. The classification is mainly divided into mild, moderate, and severe HIE. Each type presents distinct characteristics and potential prognoses.
Mild HIE is the least severe form of hypoxic ischemic encephalopathy and is characterized by subtle and transient symptoms. Given below are some of the common types of hypoxic ischemic encephalopathy:
Moderate HIE involves more noticeable and concerning symptoms, indicating a greater degree of brain injury. Key features include:
Severe HIE is the most serious form and is associated with extensive brain injury and significant neurological impairment. Key features include:
A number of grading systems are used to know the severity of HIE and predict outcomes. The most common ones include:
Hypoxic-ischemic encephalopathy (HIE) is a type of brain injury caused by a reduction in oxygen (hypoxia) and blood flow (ischemia) to the brain. This condition can occur during pregnancy, labor, delivery, or the neonatal period. Several factors can contribute to HIE, and understanding these causes is crucial for prevention and management. Here are the primary causes categorized into prenatal, perinatal, and postnatal factors:
Prenatal Causes
Perinatal Causes
Postnatal Causes
Additional Contributing Factors
Diagnosing hypoxic-ischemic encephalopathy (HIE) promptly is crucial for initiating appropriate interventions to minimize brain damage and improve outcomes. The diagnosis involves a combination of clinical assessment, laboratory tests, and advanced imaging techniques. Given below are the key components involved in diagnosing HIE:
Clinical Assessment
Apgar Scores:
Apgar scores are assigned at 1 and 5 minutes after birth based on heart rate, respiratory effort, muscle tone, reflex irritability, and color.
Low scores (especially if prolonged) can indicate distress and the need for further evaluation.
Neurological Examination:
Alertness and Responsiveness: Assessing the infant’s level of consciousness, ranging from alert to lethargic or comatose.
Muscle Tone: Checking for hypotonia (reduced muscle tone) or hypertonia (increased muscle tone).
Reflexes: Evaluating primitive reflexes such as the Moro reflex, sucking reflex, and grasp reflex.
Seizures: Observing for any seizure activity, which is common in moderate to severe HIE.
Laboratory Tests
Blood Gas Analysis:
Arterial Blood Gas (ABG): Measures pH, oxygen, and carbon dioxide levels in the blood. Acidosis (low pH) indicates poor oxygenation.
Lactate Levels: Elevated lactate can indicate anaerobic metabolism due to hypoxia.
Complete Blood Count (CBC):
Evaluate overall health and detect infections, anemia, and other abnormalities that may contribute to or result from HIE.
Electrolytes and Metabolic Panel:
Assesses for imbalances that could exacerbate or result from the hypoxic-ischemic event.
Imaging Studies
Cranial Ultrasound:
Often the first imaging modality is used due to its safety and accessibility.
Can identify gross structural abnormalities, hemorrhage, or edema.
Magnetic Resonance Imaging (MRI):
MRI with Diffusion-Weighted Imaging (DWI): Highly sensitive in detecting early brain injury, often within the first few days of life.
Provides detailed images of brain structure and can identify specific areas of injury, helping to assess the extent and severity of HIE.
Magnetic Resonance Spectroscopy (MRS):
Complements MRI by assessing the metabolic status of brain tissues.
Helps detect metabolic abnormalities associated with hypoxic injury.
Electroencephalography (EEG)
Continuous Video EEG Monitoring:
Monitors brain activity for seizures and evaluates overall brain function.
Can help determine the severity of encephalopathy and guide treatment decisions.
Amplitude-Integrated EEG (aEEG):
Simplified version of EEG used for continuous monitoring in the neonatal intensive care unit (NICU).
Useful for early detection of seizures and assessing the severity of brain injury.
Additional Diagnostic Tools
Echocardiogram:
Evaluate heart function and detect congenital heart defects that might contribute to or result from HIE.
Umbilical Cord Blood Analysis:
Tests blood gases and pH from the umbilical cord at birth, providing immediate information about the newborn’s oxygenation status at delivery.
Early Interventions and Follow-Up
Once HIE is suspected or diagnosed, immediate interventions such as therapeutic hypothermia (cooling therapy) can be initiated to reduce the extent of brain injury. This treatment is most effective when started within six hours of birth.
Regular follow-up with pediatric neurology, developmental assessments, and continued imaging studies are crucial to monitor progress and manage any long-term effects of HIE.
Multidisciplinary care involving neonatologists, neurologists, physical therapists, and other specialists is often necessary to support the infant’s development and address any complications
The treatment of hypoxic ischemic encephalopathy helps to minimize brain damage. It includes immediate interventions and stabilizes the patient. There are therapies to promote brain injury and long-term management strategies. Given below is the treatment for hypoxic ischemic encephalopathy:
Immediate Interventions
Airway Management: Ensuring the airway is clear to facilitate breathing.
Ventilation Support: Providing oxygen or mechanical ventilation to infants with breathing difficulties.
Cardiovascular Stabilization: Monitoring and supporting heart function to maintain adequate blood pressure and circulation.
Whole-Body Cooling: Reducing the infant’s body temperature to 33.5°C (92.3°F) for 72 hours to slow metabolic processes and reduce brain swelling.
Selective Head Cooling: Cooling the head while maintaining normal body temperature. This method is less commonly used than whole-body cooling.
Rewarming: Gradually rewarming the infant over a period of several hours after the cooling period to prevent rapid changes in body temperature.
Supportive Care
Antiepileptic Medications: Drugs like phenobarbital or levetiracetam are used to control seizures, which are common in infants with HIE.
Continuous EEG Monitoring: Monitoring brain activity to detect and manage seizures effectively.
Parenteral Nutrition: Providing nutrients intravenously if the infant is unable to feed orally.
Enteral Nutrition: Feeding through a tube directly into the stomach or intestines when the infant is ready for more advanced nutritional support.
Oxygen Therapy: Administering supplemental oxygen to ensure adequate oxygenation of tissues.
Mechanical Ventilation: Using ventilators to support infants who cannot breathe on their own.
Long-term Management and Therapies
Early Intervention Programs: Tailored therapy programs to enhance motor skills, strength, and coordination.
Developmental Support: Activities designed to promote cognitive and sensory development.
Feeding and Swallowing: Assisting with difficulties in feeding and swallowing.
Communication Skills: Enhancing verbal and non-verbal communication abilities.
Stem cell therapy is a promising treatment for HIE, focusing on repairing and regenerating damaged brain tissue. The mechanisms through which stem cells exert their effects include neuroprotection, neuroregeneration, and modulation of inflammation. Different types of stem cells, such as mesenchymal stem cells (MSCs) and neural stem cells (NSCs), are used for their potential to differentiate into neural cells and release neurotrophic factors.
Administration Methods:
Intravenous (IV) Injection: Delivering stem cells directly into the bloodstream.
Intrathecal Injection: Injecting stem cells into the cerebrospinal fluid.
Intra-arterial Injection: Delivering stem cells into the arteries supplying the brain.
Expected Outcomes:
Neuroregeneration: Repairing and regenerating damaged neural tissue.
Neuroprotection: Protecting existing neurons from further damage.
Reduction of Inflammation: Decreasing harmful inflammation in the brain.
Enhanced Functional Recovery: Improving cognitive, motor, and sensory functions.
Stem Cell Care India as a leading healthcare consultant in Delhi helps you to find one of the best treatments for you according to your conditions. There is a 3 day procedure that SCCI will provide you for your disease. Given below is the complete procedure for hypoxic ischemic encephalopathy:
Day 1-
Day 2-
Day 3-
Note:
The implantation of stem cell treatment for hypoxic ischemic encephalopathy (HIE) is an emerging therapeutic approach. It helped to repair brain damage and improve neurological outcomes in affected infants. The process includes a number of clinical steps such as the selection of the appropriate stem cells, their administration, and post-treatment monitoring. Given below is the completed implantation procedure of hypoxic ischemic encephalopathy:
The first and most important step is the selection of stem cells. 3 types of stem cells can be used in hypoxic ischemic encephalopathy.
The third step is to administration of stem cells and preparation.
Early intervention is critical, typically within the first few days of life when therapeutic windows are most effective. The timing of administration can significantly influence the efficacy of the treatment.
The implantation of stem cell treatment for HIE holds significant promise for improving outcomes in infants suffering from this devastating condition. The process involves careful selection and preparation of stem cells. It has precise administration methods, and thorough post-treatment monitoring to maximize the therapeutic benefits while minimizing risks. As research and clinical trials continue to advance, stem cell therapy may become an important component of HIE treatment. It offers hope for enhanced recovery and a better quality of life for affected children.
Question: What is hypoxic-ischemic encephalopathy (HIE) and how does it affect infants?
Answer: Hypoxic-ischemic encephalopathy (HIE) is a type of brain injury that occurs when an infant’s brain doesn’t receive enough oxygen and blood flow around the time of birth. This can lead to significant neurological impairment, affecting motor skills, cognitive development, and overall brain function. Symptoms vary based on severity and can include seizures, poor muscle tone, feeding difficulties, and developmental delays.
Question: How do stem cells help in treating HIE?
Answer: Stem cells have the potential to repair and regenerate damaged brain tissue in infants with HIE. They can differentiate into various cell types, including neurons and glial cells, which are essential for brain function. Additionally, stem cells release neurotrophic factors that promote neurogenesis, reduce inflammation, and protect existing neurons from further damage. These properties make stem cells a promising treatment option for improving neurological outcomes in HIE.
Question: What types of stem cells are used for treating HIE, and how are they administered?
Answer: The main types of stem cells used for treating HIE include mesenchymal stem cells (MSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs). These cells can be derived from sources such as bone marrow, umbilical cord blood, or adipose tissue. Administration methods include intravenous (IV) injection, intrathecal injection (directly into the cerebrospinal fluid), and intra-arterial injection (directly into the brain’s blood supply). The choice of stem cells and delivery method depends on the specific case and treatment goals.
Question: What are the potential risks and challenges associated with stem cell treatment for HIE?
Answer: While stem cell treatment for HIE shows promise, there are several potential risks and challenges. These include ensuring the safe and effective delivery of stem cells to the target brain tissue, minimizing the risk of immune reactions (especially with allogeneic cells), and preventing inappropriate cell differentiation. Long-term safety and efficacy need further investigation through clinical trials. Additionally, standardized protocols for stem cell preparation, administration, and monitoring are necessary to ensure consistent and reliable outcomes.
Question: What kind of improvements can be expected after stem cell treatment for HIE?
Answer: Improvements after stem cell treatment for HIE can vary depending on the severity of the condition and the timing of the intervention. Potential benefits include enhanced motor function and reduced seizure activity. It improves cognitive and sensory development and overall better neurological outcomes. Regular follow-up with developmental assessments and imaging studies helps track progress. While some infants show significant improvements, it’s important to have realistic expectations and understand that ongoing therapy and support may be needed to maximize the benefits of treatment.
Stem cell treatment for hypoxic ischemic encephalopathy (HIE) has shown promising results in improving a number of aspects of neurological function in affected infants. While the degree of improvement can vary based on the severity of the conditions and the specific of the treatment, the protocol, many areas of potential have been observed.
Motor Skills
Cognitive Development
Seizure Reduction:
Sensory processing:
Fine and Gross Motor Skills:
Behavioral Adjustments:
Emotional Stability:
Feeding and Growth:
Reduced Hospitalization:
Developmental Milestones:
Academic and Social Skills:
Independence:
The observed improvements are attributed to several key mechanisms facilitated by stem cells:
Stem cell treatment for HIE offers a promising avenue for improving various aspects of neurological function and overall quality of life in affected infants. The degree of improvement can vary, but many patients experience significant benefits in motor skills, cognitive development, sensory processing, and overall health. Ongoing research and clinical trials continue to refine these treatments, aiming to maximize their efficacy and ensure safety for all patients.
Stem cell therapy holds great promise for the treatment of hypoxic-ischemic encephalopathy (HIE), a severe brain injury caused by a lack of oxygen and blood flow around the time of birth. The effectiveness of stem cell treatment in HIE is attributed to several complex and interrelated mechanisms. Here’s a detailed overview of how stem cells contribute to brain repair and recovery:
Differentiation into Neural Cells:
Release of Neurotrophic Factors:
Anti-apoptotic Effects:
Modulation of Inflammatory Response:
Immune Modulation:
Promotion of Blood Vessel Formation:
Antioxidant Properties:
Secretion of Beneficial Molecules:
Restoration of Neural Networks:
Each family facing such problems will always want to find some hope in better treatment options. At Stem Cell Care India, we appreciate how hard this whole experience may be for our patients and their families. It is the commitment of our center to provide compassionate care and treatment options for those looking for Hypoxic Ischemic Encephalopathy stem cell treatment in India.
We try to offer proper guidance, safe treatment procedure, and individual care to all our patients. At Stem Cell Care India, we believe that each of our patients deserves an opportunity to achieve better results.
At Stem Cell Care India, we always aim to be by your side as you look for quality care and assistance in dealing with any neurological disorders. With our Hypoxic Ischemic Encephalopathy stem cell therapy in India, we make sure that the patient gets proper medical attention. We consider that all cases are unique in their own ways, hence providing proper assistance in all aspects.
The problem of Hypoxic Ischemic Encephalopathy can be dangerous for the child/patient and can create problems regarding his functioning in everyday life. Therefore, there is a requirement of affordable stem cell treatment for Hypoxic Ischemic Encephalopathy in India which can provide proper treatment without costing too much money to the patient’s family. At Stem Cell Care India, we aim at offering a treatment program which will be cost-effective and according to the requirements of the patient. In total, the price will vary based on the patient’s disease, stem cell treatment session, therapy and stay in the hospital.
Stem cell treatment costs vary from one individual to another because each condition of Hypoxic Ischemic Encephalopathy has its own significance, requiring distinct health care services. The following considerations need to be noted by those families who are looking for low-cost stem cell treatment for Hypoxic Ischemic Encephalopathy in India.
The damage that the brain suffers due to lack of oxygen at the time of delivery leads to various developmental issues for the child. Due to this reason, parents nowadays opt for stem cell treatment for Hypoxic Ischemic Encephalopathy in India to help their child recover well from the condition. The effectiveness of the procedure may differ in each individual according to the degree of brain damage, age, and health status. Certain patients can see improvement in motor skills, muscle coordination, speech, concentration, and responsiveness following the treatment process. Along with the treatment, Stem Cell Care India offers rehabilitation support to patients.
There are many critical factors that might influence the effectiveness of stem cell treatment for HIE in India. Each patient has unique circumstances, thus, there may be different outcomes as well. Some critical factors are:
Stem cell treatment is an emerging and promising treatment for hypoxic-ischemic encephalopathy (HIE). it is a condition characterized by brain injury due to lack of oxygen and blood flow. The unique properties of stem cells offer several advantages that can lead to improved outcomes for affected infants. Given below are some of the key advantages of stem cell treatment for HIE:
Quality control in stem cell therapy for Hypoxic Ischemic Encephalopathy (HIE) ensures safety and effectiveness through rigorous processes:
These measures collectively ensure that stem cell therapies for HIE are safe, reliable, and capable of delivering therapeutic benefits without adverse effects advancing treatment options for affected patients.
Regenerative medicine is providing a ray of hope for infants suffering from brain damage caused due to oxygen deficiency during childbirth. Stem cell treatment for hypoxic ischemic encephalopathy in India is emerging as an effective choice for several parents who would like to see some positive improvements in their infant’s physical and neurological development. Outcomes may vary from patient to patient since recovery will depend greatly upon several factors like age, extent of damage, and rehabilitation efforts.
Thus, in conclusion, Hypoxic Ischemic Encephalopathy stem cell treatment in India is bringing light to the lives of many parents by improving the quality of life and activities of their children step by step.
Quality and safety considerations play a very critical role whenever family members search for stem cell therapy for Hypoxic Ischemic Encephalopathy in India. At Stem Cell Care India, our aim is to provide stem cell therapy from the center that maintains quality medical standards and certification processes for treatment.
Stem Cell Care India operates under strict quality control processes in all the steps involved during the treatment. Laboratory processing, stem cell storage, testing procedures, and monitoring processes are performed under the controlled medical environment. This plays an important role in maintaining stem cell purity before therapy in the patients.
Ethical considerations along with medical treatments are also followed by our professional medical practitioners. All documentation processes, sterilization techniques, and quality checking processes are carried out effectively.
Quality and safety considerations play a very critical role whenever family members search for stem cell therapy in case of Hypoxic Ischemic Encephalopathy in India. At Stem Cell Care India, our aim is to provide stem cell therapy from the center that maintains quality medical standards and certification processes for treatment.
Stem Cell Care India operates under strict quality control processes in all the steps involved during the treatment. Laboratory processing, stem cell storage, testing procedures, and monitoring processes are performed under the controlled medical environment. This plays an important role in maintaining stem cell purity before therapy in the patients.
Ethical considerations along with medical treatments are also followed by our professional medical practitioners. All documentation processes, sterilization techniques, and quality checking processes are carried out effectively.
The follow-up care for HIE post-stem cell therapy is crucial in India. The specialists at Stem Cell Care India emphasize to parents that treatment does not end with the completion of stem cell therapy. Recovery depends upon the proper follow-up and monitoring of the patient’s health condition.
The specialists remain in touch with the patients’ family even after the completion of therapy. They assist them with medicines, therapies, exercises, daily routines, and diet. Children and patients often require physiotherapy, speech therapy, and occupational therapy along with other treatments.
In Stem Cell Care India, we have requested our patients to keep sending us their updates. This will help our doctors get information on how the body reacts to stem cell treatment for Hypoxic Ischemic Encephalopathy in India. Small variations in motor functions, speech patterns, muscle coordination, and behavioral patterns can often be observed gradually.
We even provide online follow-up services to our international and outstation patients so that they remain connected to our healthcare professionals. The main objective behind this is to ensure that all patients receive proper assistance throughout their entire recovery process.
People are experiencing a number of benefits and improvements after taking stem cell therapy because of its regenerative potential. Diseases like Hypoxic Ischemic Encephalopathy (HIE) can be treated through this innovative medical approach. There are no side effects of this therapy till now. For the information, the outcomes of stem cell therapy are different for each patient because it is still under experiments. Researchers are doing several clinical trial modifications in this treatment to make it effective for everyone. However, in its experimental stage, stem cell therapy is showing good progress among many individuals and they are living their quality of life.
India has provided a hope and healing solution for patients across the world, which can seek advanced solutions for Hypoxic Ischemic Encephalopathy. This medical condition is often a result of birth asphyxia, where the lack of oxygen and blood flow to the brain results in severe neurological challenges. The repair of damaged tissues of the brain can be an answer for this with stem cell therapy.
Given modern medical facilities, expert specialists, and affordable treatment plans, it has become India’s preference to treat patients coming from Europe, USA, UK, Bhutan, Australia, UAE, Indonesia, and South Africa. India opens the door to innovative treatments for international patients; it is also a chance for them to benefit from Hypoxic Ischemic Encephalopathy stem cell therapy in India to enhance the quality of life through medical competence combined with kindness.
What Advantages International Patients Can Take From India’s Medical System?
Facing a condition like Hypoxic Ischemic Encephalopathy requires hope and advanced solutions. That’s why stem cell therapy comes forward. India is the only place that cares about their international patients and gives them the proper care and support, so that they can live their life without any problem. International patients seeks stem cell therapy in India because:
With a combination of affordability, quality care, and innovation, makes Hypoxic Ischemic Encephalopathy stem cell treatment in India the best treatment for. International patients benefit from a seamless process, ensuring hope and better outcomes for this challenging condition.
Adequate supportive therapies will play an important role in increasing the quality of life and general wellbeing of children who undergo stem cell therapy for Hypoxic Ischemic Encephalopathy in India. Supportive therapies act together with the treatment and facilitate development physically, emotionally, and mentally of the child.
It aids children to learn and develop skills in carrying out daily activities. Children suffering from Hypoxic Ischemic Encephalopathy have difficulties when moving, grasping objects, feeding, or performing other basic activities. The therapy promotes independence and facilitates hand-eye coordination and balance.
Children suffering from the disease are sensitive to noises, touch, or strong light. In sensory integration, the brain learns how to process such information effectively. Concentration and relaxation are improved by the therapy. This therapy enhances the social behavior and learning capabilities of the children.
Proper nutrition is vital while conducting stem cell therapy on patients with Hypoxic Ischemic Encephalopathy. The condition may lead to issues with feeding and digestion. Appropriate diet modification is beneficial for improving stamina, physical endurance, and cognitive functions. Healthy nutrition improves recovery rates as well.
It is necessary to provide psychological interventions to cope with stress and anxiety experienced by the patient and parents. It will be helpful in reducing mental strain that can influence treatment efficiency. In addition, parents will know about appropriate behavior toward the child.
Children with difficulties in articulation, speech development, or swallowing abilities need speech therapy to enhance language skills and learn to communicate efficiently. It also helps to develop mouth muscles in the process.
This intervention is conducted in order to provide patients with additional oxygen inside a sealed chamber. An increased amount of oxygen in the body may positively influence the healing process due to increased oxygen concentration in brain cells. Children often become more focused and active after the procedure.
HIE can have a profound impact on the overall physical, emotional, and cognitive development of the child. Today, a lot of people have started considering stem cell therapy for HIE in India as one of the complementary treatment options available to them. Besides stem cell therapy, there are other factors such as rehabilitation, supportive therapies, follow-up care, and emotional support that play an important role in the healing process. Stem Cell Care India always gives priority to personalized treatments and safety measures when dealing with its clients.
National Library of Medicine (PubMed) – Stem Cell Therapy in Neonates with Hypoxic-Ischemic Encephalopathy: A Systematic Review and Meta-analysis
This government medical database article explains that stem cell therapy may help improve neurodevelopmental outcomes in children with Hypoxic Ischemic Encephalopathy. It also discusses safety outcomes and follow-up observations after treatment.
Link: https://pubmed.ncbi.nlm.nih.gov/40847199/
National Center for Biotechnology Information (NCBI) – Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
This review explains how stem cell therapy may support improvement in motor skills, cognitive function, brain repair, and rehabilitation in Hypoxic Ischemic Encephalopathy patients. It also discusses the importance of supportive therapies and long-term recovery monitoring.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8003344/
PubMed – Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy
This article discusses the role of stem cell therapy in neonatal HIE and explains how rehabilitation programs, monitoring, and supportive care may help improve patient outcomes after treatment.
Link: https://pubmed.ncbi.nlm.nih.gov/25161645/
PubMed – The Fate and Prospects of Stem Cell Therapy in the Treatment of Hypoxic-Ischemic Encephalopathy
This publication explains the possible therapeutic benefits of stem cell treatment for brain injury caused by oxygen deprivation and highlights the importance of recovery support, neurological improvement, and regenerative medicine approaches.
Link: https://pubmed.ncbi.nlm.nih.gov/37161514/
PubMed – Neonatal Hypoxic-Ischemic Encephalopathy: Emerging Therapeutic Strategies Based on Pathophysiologic Phases of the Injury
This article explains different treatment strategies for Hypoxic Ischemic Encephalopathy, including supportive care, rehabilitation therapies, and emerging regenerative medicine approaches that may assist recovery in affected children.
Link: https://pubmed.ncbi.nlm.nih.gov/29681183/
Beyond neurological care — exploring holistic treatments for a better quality of life.
Our Experts Are Available To Answer All Your Questions.
Discover how stem cell therapy is making a difference in a wide range of diseases and helping patients lead healthier, better lives.
